Texas SB 166: Relating to a limit on cost-sharing requirements imposed by a health benefit plan for certain prescription insulin.

Status: Referred to Business & Commerce (as of 2021-03-03)

State: Texas · Session: 87 · Bill: SB 166

Subjects: Health--Other Diseases & Medical Conditions (I0383), Insurance--Health & Accident (I0422), MEDICINE & PRESCRIPTION DRUGS (S7338), PHARMACIES & PHARMACISTS (S1192), PHARMACY BENEFIT MANAGERS (S0648)

Sponsors: Blanco

View Texas SB 166 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.